与年龄相关的透镜形状变化对儿科白内障患者观察到的后方囊化风险增加的影响
Samira Izuagbe1, Tejas Alankar1, Katherine Zoller1
1Department of Bioengineering, College of Engineering, University of Texas at Arlington, Arlington, TX, USA.
Translational vision science & technology
|January 23, 2026
概括
儿科白内障患者经历较高的后囊模糊率 (PCO) 由于标准眼内透镜 (IOL) 和较小的儿科透镜之间的不匹配. 这项研究表明,在年轻患者中,IOL-后视镜囊 (PLC) 接触减少会增加PCO风险.
科学领域:
- 眼科医生 眼科 眼科
- 生物材料科学 生物材料科学
- 细胞生物学 细胞生物学
背景情况:
- 后囊模糊化 (PCO) 在儿科白内障患者中比成人更为普遍.
- 这部分归因于年轻透镜上皮细胞 (LEC) 增强的增殖能力.
- 眼内透镜 (IOL) 和后侧透镜囊 (PLC) 之间的物理相互作用是PCO发展的关键因素.
研究的目的:
- 调查标准成人尺寸的IOL是否会与儿科PLC产生低于最佳的接触,从而导致更高的PCO率.
- 了解镜头形状的年龄相关差异如何影响IOL-PLC接口上的LEC行为.
主要方法:
- 制造模拟PLC (sPLC),模仿儿科 (8岁),年轻成人 (25岁) 和老年成人 (65岁) 镜片的尺寸和曲率.
- 使用光学连贯断层扫描 (OCT) 和粘附力测试量化的IOL-sPLC物理相互作用.
- 在不同的sPLC接口上评估年轻小鼠和成年小鼠的LEC反应 (透,增殖,上皮-介质细胞转分 (EMT)).
主要成果:
- 8岁的sPLC与IOL接触最少,其次是25岁和65岁的sPLC.
- 与较旧的接口相比,年轻和成人LEC在IOL-8y-sPLC接口上表现出更高的响应.
- 较低的IOL-PLC接触,特别是与儿科的sPLC接触,与增加的LEC反应相关.
结论:
- 儿科PLC和标准IOL之间的尺寸和曲率不匹配是儿科PCO率升高的重要因素.
- 优化针对特定年龄组的内腔镜设计可能会减少儿科白内障手术中PCO发生率.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
271
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
199
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
260
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
192
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
192
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
246
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
246